{"owner": "ArrayExpress Uploader", "pop_total": 0, "id": 3795, "factors": [{"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}, {"GSM589933": {"compound": "none", "dose": "  "}}, {"GSM589934": {"compound": "LY2109761", "dose": "2"}}], "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "TGF-beta has an oncogenic response in glioblastoma and it is considered to be a therapeutic target. We evaluated the effect of TGF-beta...", "pubmed_id": 21156287, "geo_gse_id": "E-GEOD-23935", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 2, "sample_count": 22, "tags": ["cell", "left"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "transcription-profiling-by-array-of-human-gliobl-6", "geo_id_plat": "E-GEOD-23935_A-AFFY-44", "name": "Transcription profiling by array of human glioblastoma samples after treatment with LY2109761", "created": "Sep.15, 2014", "summary": "TGF-beta has an oncogenic response in glioblastoma and it is considered to be a therapeutic target. We evaluated the effect of TGF-beta inhibition in glioblastoma. Differential gene expression analysis of patient-derived primary cultured glioblastoma cells treated with the TGF-beta receptor inhibitor, LY2109761 11 patient-derived cell cultures from 11 patients were treated with 2microM of the TGF-beta receptor inhibitor, LY2109761, for 3 hours or left untreated and RNA was isolated and microarray analysis was performed", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-23935", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-23935/samples/"}